Cargando…
The Evolution of Adenoviral Vectors through Genetic and Chemical Surface Modifications
A long time has passed since the first clinical trial with adenoviral (Ad) vectors. Despite being very promising, Ad vectors soon revealed their limitations in human clinical trials. The pre-existing immunity, the marked liver tropism and the high toxicity of first generation Ad (FG-Ad) vectors have...
Autores principales: | Capasso, Cristian, Garofalo, Mariangela, Hirvinen, Mari, Cerullo, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939484/ https://www.ncbi.nlm.nih.gov/pubmed/24549268 http://dx.doi.org/10.3390/v6020832 |
Ejemplares similares
-
Beyond Gene Delivery: Strategies to Engineer the Surfaces of Viral Vectors
por: Capasso, Cristian, et al.
Publicado: (2013) -
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity
por: Hirvinen, Mari, et al.
Publicado: (2016) -
Oncolytic adenoviruses coated with MHC-I tumor epitopes for a new oncolytic vaccine platform
por: Capasso, Cristian, et al.
Publicado: (2015) -
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma
por: Capasso, Cristian, et al.
Publicado: (2015) -
Treatment of osteoarthritis using a helper-dependent adenoviral vector retargeted to chondrocytes
por: Ruan, Merry ZC, et al.
Publicado: (2016)